1 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00105
D00105
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
2 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00105
D00105
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
3 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D02369
D02369
|
Histrelin
| [1] 76 76 |
4 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D06247
D06247
|
Triptorelin
| [2] 49 49, 76 |
5 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D08027
D08027
|
Gonadorelin
| [1] 76 76 |
6 |
AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | D00075
D00075
|
Testosterone
| [8] 1 1, 2, 3, 13, 60, 76, 78, 113 |
7 |
PGR
| [5] Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | D00066
D00066
|
Progesterone
| [2] 76 76, 299 |
8 |
PGR
| [5] Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | D00952
D00952
|
Megestrol acetate
| [1] 76 76 |